% | $
Quotes you view appear here for quick access.

Affymax, Inc. Message Board

  • dinepat203 dinepat203 Apr 3, 2013 2:54 PM Flag

    ORWIN plan to merge AFFY with ARRY ?

    Orwin holds ARRY board of directors with some mojority of shares, he is trying to bring this down with all his negatives to make it cheap?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • he knows what he is doing. He is smart cookie.

      Sentiment: Buy

    • Array BioPharma announced that John A. Orwin, CEO of Affymax, Inc., has joined the company’s Board of Directors. This development is part of Array’s continued evolution toward late-stage development and commercialization.

      Throughout his career, Mr. Orwin has built successful businesses and commercialized a range of blockbuster products. Mr. Orwin has served as Affymax’s CEO since 2011, after joining the company in 2010 as its COO. At Affymax, he led the approval and launch of Omontys®, a hematology product for the treatment of anemia in chronic kidney disease. Prior to joining Affymax, he led Genentech’s BioOncology business unit and grew a portfolio of cancer-fighting products to over $7 billion in U.S. sales.

0.061+0.0010(+1.67%)Aug 23 2:58 PMEDT